General Information of the Compound
| Compound ID |
CP0016546
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(morpholin-4-yl)-benzo[h]chromen-4-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
154447-35-5
2-(4-Morpholinyl)-4H-naphthol[1,2-b]pyran-4-one
2-(4-morpholinyl)-4H-naphtho[1,2-b]pyran-4-one
2-(Morpholin-4-yl)-benzo[h]chromen-4-one
2-morpholin-4-ylbenzo[h]chromen-4-one
2-morpholino-4H-benzo[h]chromen-4-one
AK186905
AOB2835
BCP04736
CHEBI:92165
CHEMBL104468
CTK0E7833
DNA-Dependent Protein Kinase Inhibitor II
DNA-PK Inhibitor II
DTXSID10432010
EX-A1100
Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate
GTPL5959
HMS3229C11
IN1364
KS-00000XHI
LY-293646
LY293646
MolPort-009-019-548
NU 7026
NU-7026
NU7026
SCHEMBL610237
ZINC9230
s2893
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H15NO3
|
||||||||||||||||||
| Molecular Weight |
281.311
|
||||||||||||||||||
| Canonical SMILES |
O=c1cc(oc2c3ccccc3ccc12)N1CCOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H15NO3/c19-15-11-16(18-7-9-20-10-8-18)21-17-13-4-2-1-3-12(13)5-6-14(15)17/h1-6,11H,7-10H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
KKTZALUTXUZPSN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate )
| Drug Name | Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate | ||
|---|---|---|---|
| Target(s) | |||